Bone Biologics Corporation (BBLG)
NASDAQ: BBLG · Real-Time Price · USD
1.390
+0.010 (0.72%)
At close: Jul 10, 2026, 4:00 PM EDT
1.290
-0.100 (-7.19%)
After-hours: Jul 10, 2026, 6:57 PM EDT
Bone Biologics Market Cap
Bone Biologics has a market cap or net worth of $2.5 million as of July 10, 2026. Its market cap has increased by 9.24% in one year.
Market Cap
2.50M
Enterprise Value
-2.03M
1-Year Change
9.24%
Ranking
Category
Stock Price
$1.39
Market Cap Chart
Since March 31, 2016, Bone Biologics's market cap has decreased from $155.72M to $2.50M, a decrease of -98.40%. That is a compound annual growth rate of -33.10%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 10, 2026 | 2.50M | -4.14% |
| Dec 31, 2025 | 2.60M | 12.38% |
| Dec 31, 2024 | 2.32M | -4.06% |
| Dec 29, 2023 | 2.41M | -24.75% |
| Dec 30, 2022 | 3.21M | -91.19% |
| Dec 31, 2021 | 36.43M | -58.55% |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 23, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Virax Biolabs Group | 3.25M |
| Decoy Therapeutics | 3.14M |
| GRI Bio | 3.08M |
| Clearmind Medicine | 3.02M |
| Calidi Biotherapeutics | 2.74M |
| SciSparc | 2.69M |
| Oragenics | 2.64M |
| VivoSim Labs | 2.54M |